Precision

Precision
  • ABOUT
    • OUR TEAM
    • NEWS
  • RESOURCES
    • PATIENT
    • PROVIDER
  • TESTS
    • PHARMACOGENETICS
    • COVID19/RESPIRATORY PATHOGEN PANEL
    • MOLECULAR UTI
    • MOLECULAR WOUND
  • COVID TRAVEL TESTING
  • COMPLIANCE
  • CONTACT US
    • CAREERS
    • FAQ’S
Logo

Contact Info

  • 4850 Goodman Road, Suite 101 Olive Branch, MS 38654
  • +(228) 438-2062
  • customerservice@plslab.com

Molecular UTI

    Precision > Molecular UTI

Molecular UTI Information


Standard urine culture is not always accurate in identifying susceptibility in polymicrobial infections.

PLS uses molecular technology to identify pathogens more accurately and quickly than urine culture. Average turnaround time is within 24 hours of receipt.

Resistance Genes:


PLS’s UTI testing also includes the detection of resistance genes. When detected, Resistance Genes Detected (RGD) will be indicated on the table of the report.

– Broad Spectrum resistant genes confer resistance across multiple classes of antibiotics including penicillin derivatives, cephalosporins, monobactams, and carbapenems.

– Extended-spectrum beta-lactamases (ESBL) are enzymes that are responsible for resistance to most beta-lactam antibiotics, including penicillins, cephalosporins, and the monobactam aztreonam. Infections with ESBL producing organisms have been associated with poor outcomes.

Treatment Options for Sexually Transmitted Infections:


PLS’s UTI test also looks for the presence of organisms known to cause sexually transmitted infections. Please follow the links below:

– Chlamydia trachomatis
– Neisseria gonorrhoeae
– Trichomonas vaginalis

PLS LAB is a market leader in providing targeted, molecular diagnostics that can improve clinical and economic outcomes.

Get in touch →

CLIA #25D2230030

Partner
k

4850 Goodman Road, Suite 101 Olive Branch, MS 38654.

 

logo-clia-4-1

CLIA# 25D2230030

(228) 438-2062     customerservice@plslab.com

Precision Life Sciences © 2021 All Right Reserved